Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
April 24, 2018 at 13:27 PM EDT
LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc , Eli Lilly and Co and other makers of new migraine medicines to try and fix it.
